TI
FATE icon

Telemetry Investments’s Fate Therapeutics FATE Stock Holding History

Telemetry Investments’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40,000
Closed -$454K – 139
2018
Q2 		$454K Sell
40,000
-30,200
-43% -$333K 0.54% 64
2018
Q1 		$685K Sell
70,200
-20,923
-23% -$200K 0.75% 66
2017
Q4 		$557K Sell
91,123
-68,877
-43% -$307K 0.71% 71
2017
Q3 		$634K Sell
160,000
-65,700
-29% -$223K 0.65% 62
2017
Q2 		$731K Buy
225,700
+75,700
+50% +$290K 0.82% 57
2017
Q1 		$682K Buy
150,000
+26,500
+21% +$96.9K 0.75% 51
2016
Q4 		$310K Buy
123,500
+16,950
+16% +$45.4K 0.41% 69
2016
Q3 		$332K Buy
106,550
+21,550
+25% +$52.3K 0.38% 61
2016
Q2 		$144K Sell
85,000
-11,500
-12% -$20.9K 0.16% 103
2016
Q1 		$174K Buy
96,500
+26,507
+38% +$54.6K 0.16% 90
2015
Q4 		$236K Buy
+69,993
New +$294K 0.15% 104

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return